Brief: Armata Pharmaceuticals Announces $20 Million Investment To Support Advancement Of The Company's Bacteriophage Development Programs

Innoviva

27/01/2021 12:19

Jan 27 (Reuters) - Armata Pharmaceuticals Inc  ARMP.A :
    * ARMATA PHARMACEUTICALS ANNOUNCES $20 MILLION INVESTMENT TO
SUPPORT ADVANCEMENT OF THE COMPANY'S BACTERIOPHAGE DEVELOPMENT
PROGRAMS
    * ARMATA PHARMACEUTICALS - ENTERED AGREEMENT TO SELL CO'S
COMMON
STOCK, WARRANT SECURITIES TO INNOVIVA STRATEGIC OPPORTUNITIES
LLC
    * ARMATA PHARMACEUTICALS INC - TO USE NET PROCEEDS FOR
ONGOING
ADVANCEMENT OF ITS BACTERIOPHAGE DEVELOPMENT PROGRAMS

Source text for Eikon:  ID:nPnDSN8ra 
Further company coverage:  ARMP.A 

 ((Reuters.Briefs@thomsonreuters.com;))